Typicality: | 0.214 |
Saliency: | 0.122 |
because of adverse effects | 3 | cause |
therapy → be discontinued in → approximately 5% of patients | 3 |
therapy → be discontinued in → approximately 3% of patients | 3 |
negative | neutral | positive |
0.786 | 0.207 | 0.007 |
Raw frequency | 6 |
Normalized frequency | 0.122 |
Modifier score | 0.500 |
Perplexity | 22.657 |